• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gemini Therapeutics Inc (NQ: GMTX )

    N/A UNCHANGED
    Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Gemini Therapeutics Inc

    < Previous 1 2 3 Next >
    Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket
    Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. 
    Via Benzinga
    7 Short-Squeeze Stocks for Bold Contrarians to Consider
    While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists. 
    Via InvestorPlace
    Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company
    Via Benzinga
    GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLP
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
      
    Via Benzinga
    Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
    Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
    Via Benzinga
    Gemini Therapeutics and Disc Medicine Announce Merger Agreement
    From Gemini Therapeutics, Inc.
    Via Business Wire
    The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    10 Biggest Price Target Changes For Friday
    Needham cut the price target on OppFi Inc. (NYSE: OPFI) from $10 to $4.5. OppFi shares rose 5.3% to $3.20 in pre-market trading. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022
    Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra... 
    Via Benzinga
    What 5 Analyst Ratings Have To Say About Gemini Therapeutics
    Within the last quarter, Gemini Therapeutics (NASDAQ:GMTX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
    Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
    Via Benzinga
    10 Biggest Price Target Changes For Thursday
    Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading. 
    Via Benzinga
    Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold
    Jefferies has cut Gemini Therapeutics Inc (NASDAQ: GMTX) to Hold as the Company explores alternatives. The analyst Chris Howerton has also reduced the price target... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
    Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
    Via Benzinga
    10 Biggest Price Target Changes For Tuesday
    Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading. 
    Via Benzinga
    Gemini Therapeutics Provides Corporate Update
    From Gemini Therapeutics, Inc.
    Via Business Wire
    Gemini Therapeutics Provides GEM103 Program Update
    From Gemini Therapeutics, Inc.
    Via Business Wire
    46 Biggest Movers From Yesterday
    Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on... 
    Via Benzinga
    Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update
    Toward the end of trading Wednesday, the Dow traded up 0.35% to 35,669.27 while the NASDAQ rose 0.44% to 15,304.76. The S&P also rose, gaining 0.51% to 4,657.83. The U.S. has... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Biofrontera (NASDAQ: 
    Via Benzinga
    Gemini Therapeutics Shares Jump As HC Wainwright Sees Over 500% Upside
    H.C. Wainwright initiated coverage of Gemini Therapeutics Inc (NASDAQ: GMTX) with a Buy rating and $20 price target. In the near term, the expected... 
    Via Benzinga
    Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb
    Midway through trading Wednesday, the Dow traded down 0.30% to 35,436.90 while the NASDAQ fell 0.57% to 15,150.48. The S&P also fell, dropping 0.23% to 4,623.57. The U.S. has... 
    Via Benzinga
    36 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
    Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.